Hepatocelular Carcinoma Misdiagnosed as Focal Nodular Hyperplasia. Case Report

Authors

  • Muhammad Yunus Rosyidi
  • Ardhi Tripriyanggara

DOI:

https://doi.org/10.63682/jns.v14i7.4434

Keywords:

Focal Nodular Hyperplasia, Hepatocellular Carcinoma, Biopsy, CT scan, Histology

Abstract

Introduction: Focal Nodular Hyperplasia (FNH) often mimics Hepatocellular Carcinoma (HCC) in imaging, making biopsy essential to confirm the correct diagnosis. A clear understanding of FNH's features is necessary to avoid misdiagnosis and improper treatment. Case Report: A 29-year-old woman experienced lumps and pain in the upper abdomen. Her lab results showed an AFP level of 76 ng/mL. The CT scan revealed a solid mass with central scarring in the left liver lobe, measuring approximately 3.9 x 4.7 x 3.5 cm, consistent with FNH. The core biopsy indicated liver tissue with cholestasis and no malignancy. However, following resection of the left liver lobe, pathology confirmed hepatocellular carcinoma (HCC). Discussion: The CT scan showed a solid mass characteristic of FNH, and the core biopsy also supported FNH. However, post-resection pathology revealed HCC. This difference was due to the smaller tissue sample obtained through core biopsy, as open biopsy provides a more comprehensive sample, allowing for a more accurate assessment of malignancy, a clearer diagnosis, and better guidance for treatment. Conclusion: Understanding the characteristics of FNH is essential from CT Scan, and biopsy should be considered the gold standard for accurate diagnosis. Open biopsy, with its larger tissue sample, can improve diagnostic precision

Downloads

Download data is not yet available.

Metrics

Metrics Loading ...

References

G. N. Ioannou, M. F. Splan, N. S. Weiss, G. B. McDonald, L. Beretta, and S. P. Lee, “Incidence and predictors of hepatocellular carcinoma in patients with cirrhosis,” Clin. Gastroenterol. Hepatol., vol. 5, no. 8, pp. 938–945, 2007, doi: 10.1016/j.cgh.2007.02.039.

L. Luo et al., “Rare benign liver tumors that require differentiation from hepatocellular carcinoma: focus on diagnosis and treatment,” J. Cancer Res. Clin. Oncol., vol. 149, no. 7, pp. 2843–2854, 2023, doi: 10.1007/s00432-022-04169-w.

[E. F. Widiastari, W. A. Graha, and M. Pardede, “Lung Bullae Due to Septic Pulmonary Embolism in a 4-Year-Old Child: A Case Report,” Pharmacol. Med. Reports, Orthop. Illn. Details, vol. 1, no. 3, 2022, doi: 10.55047/comorbid.v1i3.355.

Z.-Y. Yang and G.-Q. Bao, “Focal nodular hyperplasia misdiagnosed as hepatocellular carcinoma: a case report and literature review,” Dig. Med. Res., vol. 4, no. 17, pp. 1–8, 2021, doi: 10.21037/DMR-20-157.

T. K. Kim, E. Lee, and H.-J. Jang, “Imaging findings of mimickers of hepatocellular carcinoma,” Clin. Mol. Hepatol., vol. 21, no. 4, pp. 326–343, 2015, doi: 10.3350/CMH.2015.21.4.326.

[A. Kitao et al., “Differentiation between hepatocellular carcinoma showing hyperintensity on the hepatobiliary phase of gadoxetic acid–enhanced MRI and focal nodular hyperplasia by CT and MRI,” Am. J. Roentgenol., vol. 211, no. 2, pp. 347–357, 2018, doi: 10.2214/AJR.17.19341.

J. W. Van den Esschert, T. M. Van Gulik, and S. S. K. S. Phoa, “Imaging modalities for focal nodular hyperplasia and hepatocellular adenoma,” Dig. Surg., vol. 27, no. 1, pp. 46–55, 2010, doi: 10.1159/000268407.

[A. Riski Apriady, Y. Wibisono, and A. Nugraha Hermawan, “Headache Profile And Associated Symptoms In Intracranial Tumors,” Pharmacol. Med. REPORTS, Orthop. Illn. DETAILS, vol. 1, no. 1, 2022, doi: 10.55047/comorbid.v1i1.36.

N. Darai, R. Shu, R. Gurung, X. Zhang, and G. Teng, “Atypical CT and MRI features of focal nodular hyperplasia of liver: a study with radiologic-pathologic correlation,” Open J. Radiol., vol. 5, no. 3, pp. 131–141, 2015, doi: 10.4236/ojrad.2015.53020.

K. G. Ishak and L. Rabin, “Benign tumors of the liver,” Med. Clin. North Am., vol. 59, no. 4, pp. 995–1013, 1975, doi: 10.1016/S0025-7125(16)31998-8.

D. J. Rowan et al., “Diagnostic challenges of focal nodular hyperplasia: interobserver variability, accuracy, and the utility of glutamine synthetase immunohistochemistry,” Histopathology, vol. 79, no. 5, pp. 791–800, 2021, doi: 10.1111/his.14424.

J. Y. Choi et al., “Focal nodular hyperplasia or focal nodular hyperplasia‐like lesions of the liver: a special emphasis on diagnosis,” J. Gastroenterol. Hepatol., vol. 26, no. 6, pp. 1004–1009, 2011, doi: 10.1111/j.1440-1746.2011.06659.x.

H. R. Makhlouf, H. M. Abdul-Al, and Z. D. Goodman, “Diagnosis of focal nodular hyperplasia of the liver by needle biopsy,” Hum. Pathol., vol. 36, no. 11, pp. 1210–1216, 2005, doi: 10.1016/j.humpath.2005.08.014.

M. S. Torbenson, “Morphologic subtypes of hepatocellular carcinoma,” Gastroenterol. Clin., vol. 46, no. 2, pp. 365–391, 2017, doi: 10.1016/j.gtc.2017.01.009.

S. Kasraeian, D. C. Allison, E. R. Ahlmann, A. N. Fedenko, and L. R. Menendez, “A comparison of fine-needle aspiration, core biopsy, and surgical biopsy in the diagnosis of extremity soft tissue masses,” Clin. Orthop. Relat. Res., vol. 468, pp. 2992–3002, 2010, doi: 10.1007/s11999-010-1401-x.

Downloads

Published

2025-04-26

How to Cite

1.
Rosyidi MY, Tripriyanggara A. Hepatocelular Carcinoma Misdiagnosed as Focal Nodular Hyperplasia. Case Report. J Neonatal Surg [Internet]. 2025Apr.26 [cited 2025Sep.19];14(7):17-22. Available from: https://www.jneonatalsurg.com/index.php/jns/article/view/4434